Observation on Clinical Effect of Edaravone Dexborneol in the Treatment of Patients with Acute Ischemic Stroke
Objective To explore the clinical effect of edaravone dexborneol in the treatment of patients with acute ischemic stroke(AIS).Methods 98 AIS patients were randomly divided into study group(49 cases)and reference group(49 cases).The reference group received routine treatment,while the study group was treated with edaravone dexborneol on the basis of the reference group.The treatment effect,neurological function,serological indicators and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the study group was 93.88%,higher than 79.59%in the reference group(P<0.05).After treatment,the NIHSS score,serum CRP and NSE levels of the study group were lower than those of the reference group(P<0.05).No statistical difference was found in the incidence of adverse reactions between the two groups(P>0.05).Conclusions Edaravone dexborneol in the treatment of AIS patients has significant effect,can significantly promote the recovery of neurological function,and improve the serum CRP and NSE levels,which is safe and reliable,and worthy of clinical promotion.
国家科技期刊平台
NSTL
万方数据
